HLB Pharmaceutical Co., Ltd (047920.KQ)
KRW 23050.0
(-1.5%)
KRW 23050.0
(-1.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.31 Billion | -2.76 Billion | -1.32 Billion | -402.62 Million | 1.35 Billion | -1.77 Billion |
| Net Income | -19.42 Billion | -11.77 Billion | -13.22 Billion | -74.84 Billion | 472.65 Million | -7.05 Billion |
| Depreciation & Amortization | 5.04 Billion | 4.53 Billion | 3.79 Billion | 2.06 Billion | 1.06 Billion | 1.14 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 543.36 Million | 435.63 Million | 315.45 Million | 56.59 Million | - | - |
| Change in working capital | -5.5 Billion | -4.49 Billion | -6.91 Billion | -3.96 Billion | -2.25 Billion | 1.55 Billion |
| Other non-cash items | 18.19 Billion | 24.21 Billion | 31.4 Billion | 81.49 Billion | 7.52 Billion | 2.99 Billion |
| Investing Cash Flow | 9.58 Billion | -13.28 Billion | -15.75 Billion | -56.11 Billion | -6.93 Billion | 309.08 Million |
| Investments in PPE | -4.25 Billion | -2.9 Billion | -49.51 Billion | -2.98 Billion | -1.93 Billion | -1.37 Billion |
| Acquisitions | 7.43 Billion | 159.66 Million | 178.37 Million | 113.94 Million | 4 Million | 24 Million |
| Investment purchases | -20.46 Billion | -58.15 Billion | -37.45 Billion | -65.7 Billion | -35.87 Billion | -14.6 Billion |
| Sales/Maturities of investments | 33.93 Billion | 48.04 Billion | 71.23 Billion | 12.75 Billion | 30.81 Billion | 16.15 Billion |
| Other Investing Activities | 365.79 Million | -424.35 Million | -200.89 Million | -296.16 Million | 53.26 Million | 105 Million |
| Financing Cash Flow | 3.75 Billion | 19.14 Billion | 9.63 Billion | 67.85 Billion | 5.29 Billion | -851.25 Million |
| Debt repayment | -4.4 Billion | -20 Billion | -10.35 Billion | -38.22 Billion | -5.29 Billion | -851.25 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 363.57 Million | - | - | 29.62 Billion | - | - |
| Other Financing Activities | -1 Billion | -10.00 | - | - | -3.65 Billion | - |
| Accounts receivables | -2.15 Billion | -3.38 Billion | -4.9 Billion | -350.1 Million | -3.06 Billion | 1.32 Billion |
| Accounts payables | -929.06 Million | 3.35 Billion | 1.39 Billion | 735.15 Million | - | 946.47 Million |
| Inventory | -3.45 Billion | -6.15 Billion | -5.28 Billion | -1.41 Billion | -266.02 Million | -397.12 Million |
| Other working capital | 1.03 Billion | 1.68 Billion | 1.88 Billion | -2.94 Billion | 1.07 Billion | -316.23 Million |
| Cash at beginning of period | 9.74 Billion | 6.63 Billion | 14.08 Billion | 2.74 Billion | 3.02 Billion | 5.34 Billion |
| Cash at end of period | 4.76 Billion | 9.74 Billion | 6.63 Billion | 14.08 Billion | 2.74 Billion | 3.02 Billion |
| Capital Expenditure | -4.25 Billion | -2.9 Billion | -49.51 Billion | -2.98 Billion | -1.93 Billion | -1.37 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.97 Billion | 3.1 Billion | -7.44 Billion | 11.33 Billion | -286.08 Million | -2.31 Billion |
| Free Cash Flow | -22.57 Billion | -5.66 Billion | -50.83 Billion | -3.38 Billion | -583.94 Million | -3.15 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 496.29 Million | -1.6 Billion | 5.18 Billion | -19.42 Billion | -7.64 Billion | -17.68 Billion |
| Depreciation & Amortization | 1.28 Billion | 1.31 Billion | 1.31 Billion | 5.04 Billion | 1.31 Billion | 1.25 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 71.74 Million | 71.74 Million | 104.57 Million | 543.36 Million | 141.56 Million | 140.13 Million |
| Change in working capital | 801.26 Million | 227.77 Million | 2.29 Billion | -5.5 Billion | -4.15 Billion | 540.12 Million |
| Other non-cash items | 1.93 Billion | 5.18 Billion | -8.01 Billion | 18.19 Billion | 4.71 Billion | 15.42 Billion |
| Investing Cash Flow | -509.34 Million | -6.74 Billion | -2.23 Billion | 9.58 Billion | 6.79 Billion | 5.27 Billion |
| Investments in PPE | -527.34 Million | -1.18 Billion | -2.02 Billion | -4.25 Billion | -684.67 Million | -914.61 Million |
| Acquisitions | 48 Million | 149.88 Million | -46 Million | 7.43 Billion | 46 Million | - |
| Investment purchases | - | -10.8 Billion | -5.66 Billion | -20.46 Billion | -5 Billion | -7.8 Billion |
| Sales/Maturities of investments | - | 5.08 Billion | 5.5 Billion | 33.93 Billion | 12.43 Billion | 14 Billion |
| Other Investing Activities | -30 Million | - | -10.00 | 365.79 Million | 10.00 | -14.21 Million |
| Financing Cash Flow | 25.09 Million | 11.27 Billion | 4.14 Billion | 3.75 Billion | 106.02 Million | -250.62 Million |
| Debt repayment | - | -10.9 Billion | -4.4 Billion | -4.4 Billion | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 287.08 Million | 626.9 Million | -10.00 | 363.57 Million | 363.57 Million | - |
| Other Financing Activities | -261.98 Million | - | - | - | - | - |
| Accounts receivables | 215.21 Million | 137.22 Million | 1.62 Billion | -2.15 Billion | 804.63 Million | 431.94 Million |
| Accounts payables | 233.34 Million | -275.24 Million | -255.38 Million | -929.06 Million | -1.79 Billion | -2.76 Billion |
| Inventory | 777.63 Million | -99.33 Million | 107.1 Million | -3.45 Billion | 166.53 Million | -1.32 Billion |
| Other working capital | -424.93 Million | 465.13 Million | 821.75 Million | 1.03 Billion | -3.33 Billion | 4.19 Billion |
| Cash at beginning of period | 11.54 Billion | 4.76 Billion | 3.23 Billion | 9.74 Billion | 5.54 Billion | 7.14 Billion |
| Cash at end of period | 14.23 Billion | 11.54 Billion | 4.76 Billion | 4.76 Billion | 3.23 Billion | 5.54 Billion |
| Capital Expenditure | -527.34 Million | -1.18 Billion | -2.02 Billion | -4.25 Billion | -684.67 Million | -914.61 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.68 Billion | 6.78 Billion | 1.53 Billion | -4.97 Billion | -2.31 Billion | -1.59 Billion |
| Free Cash Flow | 2.64 Billion | 1.07 Billion | -2.39 Billion | -22.57 Billion | -9.9 Billion | -7.53 Billion |
TRR
GENCON
TMVWY
PICCADIL
AWLCF
2155